Industry Insights
|
Gavin: The Broken Disability Safety Net | 10/27/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| Much has been said and written on the topic of the recent report from the U.S. Department of Labor regarding the supposed inadequacy of the workers' compensation system. Critics rightly point out that the report appears to reduce its own credibility by failing to exhibit a sufficient understa...Read More | |||
|
Gavin: The Guts to Buck the Lobbyists | 10/10/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | Popular with Legal | |||
| Ohio has proposed something novel: Let's not pay for expensive naloxone prescriptions and instead invest resources in ensuring the delivery of appropriate medical care and provide help for those struggling with dependence and addiction. ...Read More | |||
|
Gavin: The Solution to Every Health Care Debate: Access vs. Cost | 09/30/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | Popular with Legal | |||
| Two things you need to know about Suboxone (or buprenorphine) highlight the essential elements of all past, present and future health care debates. ...Read More | |||
|
Gavin: Bad Pharma: This Is What We're Up Against | 09/20/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | Popular with Legal | |||
| We all know that lobbyists exist. We all know the role they play in American politics, however frustrating that fact might be to us. We all know that pharmaceutical companies have plenty of them, and they appear to be pretty good at their jobs. ...Read More | |||
|
Gavin: FDA and Off-Label Drug Use: Danger Ahead | 09/13/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| The Food and Drug Administration has scheduled hearings for November (and a public comment period that will extend to January) regarding the agency's current approach to the marketing of off-label uses of FDA-...Read More | |||
|
Gavin: Health Literacy and Pain Management: How to Do Patient Education | 08/17/2016 | |
|---|---|---|---|
| State: NY | Segment: Top | 0 | |||
| Whether or not opioid pain medication might actually worsen pain is a legitimate clinical discussion and an important claims management topic. While the phenomenon is researched and written about in medical journals, talked about at various conferences and acknowledged among physicians, I ha...Read More | |||
|
Gavin: Nuance Is Necessary in the Naloxone Debate | 08/08/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| American Medical Association white paper headline: "Help save lives: Increase access to naloxone" New York Times headline: "Naloxone Saves Lives, but Is No Cure in Heroin Epidemic" ...Read More | |||
|
Gavin: What Will $180 Million Buy Us? | 08/01/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| The U.S. Senate in mid-July voted 92-2 to pass a piece of legislation, one already passed by the House 407-5. Can you remember the last time you saw a vote tally like that in Congress? ...Read More | |||
|
Gavin: Lawmakers Dictate to Doctors: New Legislative Approaches to Opioids | 07/14/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| Amidst all the talk of seven-day initial opioid script limits in New York, Massachusetts and New Hampshire (with New Jersey, Connecticut and others likely not far behind), we appear to have missed a piece of legislation that, in my view, represents the single most stringent legal construct f...Read More | |||
|
Gavin: The Biopsychosocial Model: Challenges in Application | 06/24/2016 | |
|---|---|---|---|
| State: NA | Segment: Top | 0 | |||
| Hardly a day, a conference, a meeting or a case goes by without a serious discussion about the need for a "biopsychosocial" approach to injury resolution. In fact, I've recently heard griping in some circles that the discussion has run its course. "We get it ... can w...Read More | |||
